Acorda Therapeutics Inc SMA 200
Was ist das SMA 200 von Acorda Therapeutics Inc?
SMA 200 von Acorda Therapeutics Inc ist $11 -1,496.15%
Was ist die Definition von SMA 200?
SMA 200 ist ein durchschnittlicher Aktienkurs der letzten 200 Tage, berechnet als ungewichteter Mittelwert der letzten 200 Schlusskurse.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit sma 200 ähnlich Acorda Therapeutics Inc
- Incap Oyj hat SMA 200 von $11 +4.89%
- Dongfang Electric hat SMA 200 von HKD$11 -34.93%
- Frequency Electronics hat SMA 200 von $11 +16.50%
- Nevro Corp hat SMA 200 von $11 -123.55%
- Galaxy Digital hat SMA 200 von $11 -0.93%
- Lundin Mining hat SMA 200 von $11 -22.92%
- Acorda Therapeutics Inc hat SMA 200 von $11 -1,496.15%
- Budweiser Brewing APAC hat SMA 200 von HKD$11 -32.88%
- Bank of Ireland Plc hat SMA 200 von $11 +3.84%
- Vroom hat SMA 200 von $11 -58.50%
- Landcadia II hat SMA 200 von $11 -0.01%
- Neuberger Berman Municipal Fund Inc hat SMA 200 von $11 +5.45%
- GX Acquisition hat SMA 200 von $11 +9.62%